Klotho Neurosciences Ownership

Who are the major shareholders and have insiders been buying or selling?

Recent Insider Transactions

Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.

Dilution of Shares: Shareholders have been substantially diluted in the past year, with total shares outstanding growing by 141.6%.

Top 17 shareholders own 67.7% of the company

Ownership	Name	Shares	Current Value	Change %	Portfolio %
16.5%	Joseph Sinkule	3,514,932	US$1.2m	0%	no data
14.4%	Gan Min	3,063,667	US$1.1m	0%	no data
13.1%	Upper Clapton, LLC	2,773,925	US$973.6k	0%	no data
7.64%	Chardan Capital Markets, LLC., Asset Management Arm	1,625,000	US$570.4k	-0.09%	35.83%
7.57%	Geneva Holdings Company (GHC) SA	1,610,000	US$565.1k	0%	no data
2.51%	Meteora Capital, LLC	533,951	US$187.4k	36.3%	0.06%
1.88%	Shalom Hirschman	400,000	US$140.4k	0%	no data
1.76%	Samuel Zentman	375,000	US$131.6k	0%	no data
0.94%	Peter Moriarty	200,000	US$70.2k	0%	no data
0.47%	Morgan Stanley, Investment Banking and Brokerage Investments	100,000	US$35.1k	0%	no data
0.38%	MM Asset Management Inc	80,000	US$28.1k	0%	no data
0.3%	Geode Capital Management, LLC	63,234	US$22.2k	1,980%	no data
0.14%	Jon McGarity	30,000	US$10.5k	0%	no data
0.072%	UBS Asset Management AG	15,306	US$5.4k	59.5%	no data
0.047%	Gabelli & Company Investment Advisers, Inc.	10,000	US$3.5k	0%	no data
0.0012%	Bank of America Corporation, Asset Management Arm	261	US$91.8	38.1%	no data
0%	Palmer Square Capital Management LLC	1	US$0	0%	no data